MWAI
MedWellAI Inc.0.5200
+0.0000+0%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
No earnings call transcript available
Key Stats
Market Cap
3.24MP/E (TTM)
-Basic EPS (TTM)
-0.45Dividend Yield
0%Recent Filings
10-Q
Q2 FY2026 results
MedWellAI ramped revenue to $548K in Q2 FY2026 ended December 31, 2025, up sharply from $143K y/y (derived), driven by $523K product sales of GLP medications while commissions cratered 98%. Gross margins squeezed as product costs hit $395K, yet operating loss narrowed to $274K from $315K y/y amid lower G&A. Cash dwindled to $138K with $256K operating outflow; $500K note payable remains in default. Series C preferred consolidated August 1, 2025, retiring $2.1M accrued dividends but booking $242K exchange loss. New segments split 96%/4% revenue. Controls ineffective. Regulatory hurdles linger in online sales.
10-Q
Q1 FY2026 results
MedWellAI posted Q1 FY2026 revenue of $96,094, up sharply from $1,148 y/y, driven by $94,887 in new commissions while online sales ticked to $1,207. Operating loss narrowed to $(326,034) from $(588,984) y/y as G&A held steady but digital asset volatility vanished; net loss hit $(653,607), widened by $241,918 loss on Series C/D preferred exchange. Cash dwindled to $223,221 amid $170,781 operating burn, with $500,000 note in default. Swapped mezzanine preferred into $6.5M Series C liability. Controls falter without independent board.
10-K
FY2025 results
MedWellAI posted FY2025 revenue of $594,768 from new health and wellness commissions ($576,931) and online sales ($17,837), up from zero last year, yet net loss narrowed to $3.6M from $12M amid discontinued bitcoin mining. Q4 saw full goodwill impairment of $670K and intangibles of $82K after abandoning Healthy Lifestyle online sales due to regulatory hurdles, crushing acquisition momentum from August 2024. Cash climbed to $401K, buoyed by digital asset sales; no new debt issued. One customer drove 96% of revenue. Customer concentration threatens stability.
8-K
Preferred stock consolidation
MedwellAI consolidated its Series C and D Preferred Stock on August 1, 2025, via a Share Exchange Agreement with BHP Capital NY, Inc., swapping 1,500 Series C and 3,000 Series D shares for 6,500 new Series C shares. This retired $2,133,081 in accrued dividends without additional consideration. New terms grant as-converted voting, pro-rata liquidation priority, and variable conversion pricing. Cleaned up the cap table.
8-K
Name change to MWAI effective
MedwellAI, formerly Integrated Ventures, completed its name change via Nevada filing on May 30, 2025, with FINRA approving the switch to symbol MWAI effective June 18, 2025. Shares continue trading on the OTC Marketplace. No impact on shareholders' equity interests or voting rights. Purely cosmetic.
IPO
Website
Employees
Sector
Industry
ABTS
Abits Group Inc
5.57-0.12
BMNR
BitMine Immersion Technologies,
31.39+0.44
CIFR
Cipher Mining Inc.
14.99+0.25
HIVE
HIVE Digital Technologies Ltd
2.78+0.00
HWAIF
HealWELL AI Inc.
0.64+0.00
IREN
IREN LIMITED
36.59+1.11
MARA
MARA Holdings, Inc.
10.69-0.01
MIGI
Mawson Infrastructure Group Inc
4.18-0.16
WAI
Top KingWin Ltd
2.25-0.46
WULF
TeraWulf Inc.
12.99+0.50